薬剤比較
Tirzepatide vs Insulin Degludec
Compare Tirzepatide (Mounjaro) vs Insulin Degludec (Tresiba) for T2 diabetes. Dual agonist vs basal insulin: efficacy, weight, risks, warnings.
このページには比較できる項目がありません。
臨床的背景
Type 2 diabetes patients requiring injectable therapy compare dual incretin agonist tirzepatide against long-acting insulin degludec for optimal control and weight management.
結論
Tirzepatide typically outperforms basal insulin in weight and A1C for T2D but cannot replace insulin in all cases.
すべての薬剤比較